National Healthcare (NHC) CEO Stephen Flatt logs 217 and 145 share transactions

Rhea-AI Filing Summary

National Healthcare Corp’s CEO and director Stephen Flatt reported two transactions in the company’s common stock dated 12/12/2025. Each transaction used code “G” and involved the disposition of 217 and 145 shares, respectively, at a reported price of $0 per share. After these moves, he beneficially owned 60,621 shares of National Healthcare common stock in direct ownership.

The report also lists stock options held by Flatt. He beneficially owned options to purchase 6,147 shares at an exercise price of $53.94 per share expiring on 03/08/2028, 10,000 shares at $94.10 per share expiring on 03/05/2029, and 18,000 shares at $90.62 per share expiring on 02/28/2030, all shown as directly owned. Together, these details outline his current equity stake and option-based exposure to National Healthcare.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Flatt Stephen Fowler

(Last) (First) (Middle)

100 VINE STREET

(Street)

MURFREESBORO TN 37130

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NATIONAL HEALTHCARE CORP [ NHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO

3. Date of Earliest Transaction (Month/Day/Year)
12/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/12/2025		G		217	D	$0	60,766	D
Common Stock	12/12/2025		G		145	D	$0	60,621(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to Purchase Common Stock	$53.94							03/08/2024	03/08/2028	Common Stock	6,147		6,147	D
Option to Purchase Common Stock	$94.1							03/05/2025	03/05/2029	Common Stock	10,000		10,000	D
Option to Purchase Common Stock	$90.62							02/28/2026	02/28/2030	Common Stock	18,000		18,000	D

Explanation of Responses:

1. Total amount of shares beneficially owned following transactions reported for this Title of Securities on this form.

	/s/ Stephen Flatt	12/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider stock transactions did National Healthcare Corp (NHC) report for its CEO?

Stephen Flatt, CEO and director of National Healthcare Corp, reported two transactions dated 12/12/2025, each coded “G,” involving the disposition of 217 and 145 shares of common stock at a reported price of $0 per share.

How many National Healthcare (NHC) shares does CEO Stephen Flatt beneficially own after the reported transactions?

Following the 12/12/2025 transactions, CEO and director Stephen Flatt beneficially owned 60,621 shares of National Healthcare Corp common stock in direct ownership, according to the report.

What stock options in National Healthcare Corp (NHC) does Stephen Flatt hold?

Stephen Flatt beneficially owned options to purchase 6,147 shares at an exercise price of $53.94 per share expiring 03/08/2028, 10,000 shares at $94.10 per share expiring 03/05/2029, and 18,000 shares at $90.62 per share expiring 02/28/2030.

What is Stephen Flatt’s role at National Healthcare Corp (NHC) in this report?

In the report, Stephen Flatt is identified as both a director and an officer of National Healthcare Corp, serving in the role of CEO, and the report is filed by one reporting person.

Does the National Healthcare Corp (NHC) report show any derivative security transactions on 12/12/2025?

The report lists stock options held by Stephen Flatt, including positions over 6,147, 10,000, and 18,000 underlying shares with various exercise prices and expiration dates, but does not show a dated transaction entry for these derivative securities in the excerpt.